Cited by

• Gender, body mass index, and PPARγ polymorphism are good indicators in hyperuricemia prediction for Han Chinese.

  Lee MF, Liou TH, Wang W, Pan WH, Lee WJ, Hsu CT, Wu SF, Chen HH. Lee MF, et al. Genet Test Mol Biomarkers. 2013 Jan;17(1):40-6. doi: 10.1089/gtmb.2012.0231. Genet Test Mol Biomarkers. 2013. PMID: 23237621 Free PMC article.
• Prevalence of metabolic syndrome and its associated factors in Chinese patients with ankylosing spondylitis.

  Liu M, Huang Y, Huang Z, Huang Q, Guo X, Wang Y, Deng W, Huang Z, Li T. Liu M, et al. Diabetes Metab Syndr Obes. 2019 Apr 11;12:477-484. doi: 10.2147/DMSO.S197745. eCollection 2019. Diabetes Metab Syndr Obes. 2019. PMID: 31114277 Free PMC article.
• Incidence and Risk Factors of Hyperuricemia among 2.5 Million Chinese Adults during the Years 2017-2018.

  Shan R, Ning Y, Ma Y, Gao X, Zhou Z, Jin C, Wu J, Lv J, Li L. Shan R, et al. Int J Environ Res Public Health. 2021 Feb 28;18(5):2360. doi: 10.3390/ijerph18052360. Int J Environ Res Public Health. 2021. PMID: 33671018 Free PMC article.
• The joint effect of cigarette smoking and polymorphisms on LRP5, LEPR, near MC4R and SH2B1 genes on metabolic syndrome susceptibility in Taiwan.

  Yang CW, Li CI, Liu CS, Bau DT, Lin CH, Lin WY, Li TC, Lin CC. Yang CW, et al. Mol Biol Rep. 2013 Jan;40(1):525-33. doi: 10.1007/s11033-012-2089-7. Epub 2012 Oct 11. Mol Biol Rep. 2013. PMID: 23054017
• Prevalence and Risk Factors of Hyperuricemia and Gout: A Cross-sectional Survey from 31 Provinces in Mainland China.

  Song J, Jin C, Shan Z, Teng W, Li J. Song J, et al. J Transl Int Med. 2022 Jul 7;10(2):134-145. doi: 10.2478/jtim-2022-0031. eCollection 2022 Jun. J Transl Int Med. 2022. PMID: 35959454 Free PMC article.